\-\ Texto\\:\\ \ \(0\)\
\-\ no\\ laboratory\\ data\\.\ \(1\)\
\-\ patient\\ was\\ referred\\ to\\ orthopedics\\ for\\ possible\\ radiofrequency\\ ablation\\ therapy\\.\ \(0\)\
\-\ ap\\ view\\ of\\ the\\ lumbosarcral\\ spine\\ showing\\ an\\ enlarged\\ right\\ l4\\ pedicle\\ in\\ comparison\\ with\\ the\\ left\\.\\ also\\,\\ mild\\ dextrothoracic\\ and\\ levolumbar\\ scoliosis\\ is\\ present\\.\ \(0\)\
\-\ the\\ \\ oblique\\ view\\ of\\ the\\ lumbosacral\\ spine\\ showing\\ an\\ enlarged\\ right\\ pedicle\\ with\\ sclerotic\\ margin\\.\ \(0\)\
\-\ sagittal\\ ct\\ image\\ of\\ lumbar\\ spine\\ showing\\ a\\ sclerotic\\ lesion\\ in\\ the\\ right\\ l4\\ pedicle\\ with\\ central\\ nidus\\.\ \(0\)\
\-\ the\\ coronal\\ image\\ of\\ ct\\ lumbar\\ spine\\ showing\\ \\ a\\ sclerotic\\ lesion\\ in\\ the\\ right\\ l4\\ pedicle\\ with\\ central\\ nidus\\.\ \(0\)\
\-\ osteoid\\ osteoma\ \(14\)\
\-\ \\â\\€\\¢\\ osteoblastoma\ \(1\)\
\-\ \\â\\€\\¢\\ brodie\\ abscess\ \(0\)\
\-\ \\â\\€\\¢\\ sclerotic\\ metastases\ \(0\)\
\-\ \\â\\€\\¢\\ osteoma\ \(2\)\
\-\ \\â\\€\\¢\\ osteogenic\\ sarcoma\ \(0\)\
\-\ \\â\\€\\¢\\ lymphoma\ \(6\)\
\-\ this\\ eleven\\ year\\ old\\ girl\\ has\\ scoliosis\\ and\\ is\\ complaining\\ of\\ low\\ back\\ pain\\.\ \(0\)\
\-\ osteoid\\ osteoma\\ is\\ a\\ benign\\ skeletal\\ neoplasm\\ of\\ unknown\\ etiology\\.\\ the\\ tumor\\ consists\\ of\\ an\\ ovoid\\ or\\ spherical\\ nidus\\ of\\ osteoid\\-rich\\ tissue\\ and\\ interconnected\\ bone\\ trabeculae\\ superimposed\\ on\\ a\\ background\\ of\\ highly\\ vascularized\\ connective\\ tissue\\ containing\\ large\\ dilated\\ vascular\\ channels\\.the\\ average\\ size\\ of\\ the\\ nidus\\ is\\ approximately\\ 1\\.5\\ cm\\,\\ but\\ its\\ size\\ can\\ be\\ 0\\.5\\-2\\ cm\\.\\ \\ the\\ tumor\\ is\\ usually\\ smaller\\ than\\ 1\\.5\\ cm\\ in\\ diameter\\.\\ osteoid\\ osteoma\\ can\\ occur\\ in\\ any\\ bone\\,\\ but\\ in\\ approximately\\ two\\ thirds\\ of\\ patients\\,\\ the\\ appendicular\\ skeleton\\ is\\ involved\\.\\ the\\ skull\\ and\\ facial\\ bones\\ are\\ involved\\ exceptionally\\.\ \(0\)\
\-\ osteoid\\ osteoma\\ more\\ commonly\\ affects\\ males\\ than\\ females\\.\\ the\\ male\\-to\\-female\\ ratio\\ is\\ 2\\:1\\.most\\ patients\\ with\\ osteoid\\ osteoma\\ are\\ young\\ with\\ three\\ quarters\\ of\\ patients\\ are\\ aged\\ 10\\-30\\ years\\,and\\ more\\ than\\ 90\\%\\ of\\ patients\\ are\\ aged\\ 5\\-25\\ years\\.\ \(0\)\
\-\ the\\ classic\\ presentation\\ includes\\ focal\\ skeletal\\ bone\\ pain\\,\\ which\\ worsens\\ at\\ night\\ and\\ is\\ frequently\\ relieved\\ with\\ a\\ small\\ dose\\ of\\ aspirin\\.\\ pain\\ that\\ increases\\ with\\ activity\\ and\\ at\\ night\\ occurs\\ in\\ 95\\%\\ of\\ patients\\ with\\ spinal\\ tumors\\.\\ in\\ 29\\%\\ of\\ patients\\,\\ the\\ pain\\ is\\ severe\\ enough\\ to\\ waken\\ the\\ patient\\.\\ the\\ site\\ of\\ involvement\\ may\\ be\\ tender\\ to\\ touch\\ or\\ pressure\\.\\ constitutional\\ symptoms\\ are\\ usually\\ absent\\.\ \(0\)\
\-\ when\\ the\\ spinal\\ column\\ is\\ involved\\,\\ muscle\\ spasms\\ may\\ cause\\ abnormal\\ alignment\\.\\ a\\ painful\\ scoliosis\\ may\\ be\\ concave\\ toward\\ the\\ lesion\\.\\ the\\ onset\\ of\\ scoliosis\\ may\\ be\\ acute\\ and\\ is\\ frequently\\ initiated\\ by\\ physical\\ exertion\\.\\ osteoid\\ osteoma\\ has\\ been\\ called\\ the\\ most\\ common\\ cause\\ of\\ painful\\ scoliosis\\.\ \(0\)\
\-\ radiography\\ is\\ the\\ initial\\ examination\\ of\\ choice\\ and\\ may\\ be\\ the\\ only\\ examination\\ required\\.\\ the\\ lesion\\ initially\\ appears\\ as\\ a\\ small\\ sclerotic\\ bone\\ island\\ within\\ a\\ circular\\ lucent\\ defect\\.\\ this\\ central\\ nidus\\ is\\ seldom\\ larger\\ than\\ 1\\.5\\ cm\\ in\\ diameter\\,\\ and\\ it\\ may\\ be\\ associated\\ with\\ considerable\\ overlying\\ cortical\\ and\\ endosteal\\ bone\\ sclerosis\\.\\ ct\\ is\\ used\\ for\\ precise\\ localization\\.\\ mri\\ is\\ a\\ useful\\ imaging\\ technique\\,\\ but\\ ct\\ appears\\ superior\\ for\\ precise\\ localization\\.\\ radionuclide\\ scanning\\ for\\ technetium\\-99m\\ diphosphonate\\ uptake\\ shows\\ fairly\\ intense\\ activity\\ at\\ the\\ tumor\\ site\\.\\ radionuclide\\ scanning\\ is\\ a\\ sensitive\\ technique\\,\\ and\\ findings\\ may\\ be\\ positive\\ before\\ radiographic\\ changes\\ are\\ apparent\\.\ \(0\)\
\-\ for\\ the\\ treatment\\ of\\ osteoid\\ osteoma\\ surgery\\,\\ conservative\\ treatment\\ with\\ nonsteroidal\\ anti\\-inflammatory\\ medications\\,\\ and\\ radiofrequency\\ ablation\\ are\\ potential\\ options\\.\\ surgery\\ is\\ frequently\\ associated\\ with\\ major\\ morbidity\\ and\\ a\\ prolonged\\ period\\ of\\ recovery\\.\\ longterm\\ drug\\ therapy\\ may\\ result\\ in\\ gastrointestinal\\ side\\ effects\\ and\\ is\\ not\\ well\\ tolerated\\ by\\ patients\\.\\ percutaneous\\ rf\\ ablation\\ is\\ performed\\ under\\ ct\\ guidance\\ by\\ using\\ general\\ or\\ spinal\\ anesthesia\\.24\\ after\\ localization\\ of\\ the\\ nidus\\ with\\ 1\\-\\ to\\ 3\\-mm\\ ct\\ sections\\,\\ an\\ osseous\\ access\\ is\\ established\\ with\\ either\\ a\\ 2\\-mm\\ coaxial\\ drill\\ system\\ or\\ an\\ 11\\-gauge\\ jamshidi\\ needle\\.\\ radiofrequency\\ ablation\\ is\\ performed\\ at\\ 90\\Â\\°c\\ for\\ 4\\-5\\ minutes\\ by\\ using\\ a\\ rigid\\ rf\\ electrode\\ with\\ a\\ 1\\-mm\\ diameter\\.\\ the\\ procedure\\ is\\ successful\\ when\\ the\\ electrode\\ is\\ heated\\ to\\ the\\ desired\\ temperature\\ within\\ the\\ nidus\\.\\ in\\ one\\ series\\,\\ clinical\\ success\\ was\\ achieved\\ in\\ 96\\%\\ of\\ patients\\.\\ all\\ recurrences\\ were\\ treated\\ with\\ a\\ second\\ procedure\\,\\ with\\ a\\ secondary\\ success\\ rate\\ of\\ 100\\%\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ osteoma\\:\\ 0\\.05982737915385131\ \(0\)\
\-\ nidus\\:\\ 0\\.05729300913345377\ \(0\)\
\-\ osteoid\\:\\ 0\\.054835163530928016\ \(0\)\
\-\ scoliosis\\:\\ 0\\.039394569375307595\ \(0\)\
\-\ pedicle\\:\\ 0\\.032738862361973584\ \(0\)\
\-\ ablation\\:\\ 0\\.03151565550024608\ \(0\)\
\-\ radiofrequency\\:\\ 0\\.03035173022788447\ \(0\)\
\-\ sclerotic\\:\\ 0\\.028167053292987937\ \(0\)\
\-\ patients\\:\\ 0\\.026056843586050378\ \(0\)\
\-\ localization\\:\\ 0\\.024554146771480188\ \(0\)\
\-\ showing\\:\\ 0\\.023167696620796038\ \(0\)\
\-\ l4\\:\\ 0\\.022331303276610908\ \(0\)\
\-\ may\\:\\ 0\\.022083397571701018\ \(0\)\
\-\ electrode\\:\\ 0\\.021882839654923734\ \(0\)\
\-\ is\\:\\ 0\\.019046668487258746\ \(0\)\
\-\ 1\\.5\\:\\ 0\\.018875804013386573\ \(0\)\
\-\ precise\\:\\ 0\\.018646868259730477\ \(0\)\
\-\ radionuclide\\:\\ 0\\.017989597121838844\ \(0\)\
\-\ rf\\:\\ 0\\.01762092807042793\ \(0\)\
\-\ aged\\:\\ 0\\.016605197624796914\ \(0\)\
\-\ spine\\:\\ 0\\.016577929578823845\ \(0\)\
\-\ frequently\\:\\ 0\\.016363169229499066\ \(0\)\
\-\ diameter\\:\\ 0\\.015884370834557467\ \(0\)\
\-\ involved\\:\\ 0\\.0158368621816432\ \(0\)\
\-\ bone\\:\\ 0\\.01563648513593424\ \(0\)\
\-\ scanning\\:\\ 0\\.015410896864537227\ \(0\)\
\-\ success\\:\\ 0\\.015330192964130407\ \(0\)\
\-\ \\%\\:\\ 0\\.014678358124786507\ \(0\)\
\-\ technique\\:\\ 0\\.014502792712388428\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.013846960397018155\ \(0\)\
\-\ be\\:\\ 0\\.013585120859215764\ \(0\)\
\-\ spinal\\:\\ 0\\.013518893418466507\ \(0\)\
\-\ cm\\:\\ 0\\.01350195062042407\ \(0\)\
\-\ than\\:\\ 0\\.013190273077574515\ \(0\)\
\-\ lumbosarcral\\:\\ 0\\.012983090462395432\ \(0\)\
\-\ dextrothoracic\\:\\ 0\\.012983090462395432\ \(0\)\
\-\ levolumbar\\:\\ 0\\.012983090462395432\ \(0\)\
\-\ osteoid\\-rich\\:\\ 0\\.012983090462395432\ \(0\)\
\-\ interconnected\\:\\ 0\\.012983090462395432\ \(0\)\
\-\ channels\\.the\\:\\ 0\\.012983090462395432\ \(0\)\
\-\ 0\\.5\\-2\\:\\ 0\\.012983090462395432\ \(0\)\
\-\ 2\\:1\\.most\\:\\ 0\\.012983090462395432\ \(0\)\
\-\ quarters\\:\\ 0\\.012983090462395432\ \(0\)\
\-\ waken\\:\\ 0\\.012983090462395432\ \(0\)\
\-\ anesthesia\\.24\\:\\ 0\\.012983090462395432\ \(0\)\
\-\ 3\\-mm\\:\\ 0\\.012983090462395432\ \(0\)\
\-\ 2\\-mm\\:\\ 0\\.012983090462395432\ \(0\)\
\-\ 11\\-gauge\\:\\ 0\\.012983090462395432\ \(0\)\
\-\ jamshidi\\:\\ 0\\.012983090462395432\ \(0\)\
\-\ 90\\Â\\°c\\:\\ 0\\.012983090462395432\ \(0\)\
\-\ 1\\-mm\\:\\ 0\\.012983090462395432\ \(0\)\
\-\ skeletal\\:\\ 0\\.012431218185071896\ \(0\)\
\-\ central\\:\\ 0\\.012422524404388626\ \(0\)\
\-\ night\\:\\ 0\\.012229983298540298\ \(0\)\
\-\ are\\:\\ 0\\.012009008995150533\ \(0\)\
\-\ painful\\:\\ 0\\.011964442512106432\ \(0\)\
\-\ coaxial\\:\\ 0\\.011962255144928649\ \(0\)\
\-\ male\\-to\\-female\\:\\ 0\\.011365104764798805\ \(0\)\
\-\ 10\\-30\\:\\ 0\\.011365104764798805\ \(0\)\
\-\ 5\\-25\\:\\ 0\\.011365104764798805\ \(0\)\
\-\ longterm\\:\\ 0\\.011365104764798805\ \(0\)\
\-\ drill\\:\\ 0\\.011365104764798805\ \(0\)\
\-\ heated\\:\\ 0\\.011365104764798805\ \(0\)\
\-\ eleven\\:\\ 0\\.010941419827461867\ \(0\)\
\-\ using\\:\\ 0\\.010926577172506384\ \(0\)\
\-\ lumbar\\:\\ 0\\.010703195504195621\ \(0\)\
\-\ site\\:\\ 0\\.010637737074785575\ \(0\)\
\-\ vascularized\\:\\ 0\\.010612784258516049\ \(0\)\
\-\ exceptionally\\:\\ 0\\.010612784258516049\ \(0\)\
\-\ ct\\:\\ 0\\.010562329779605681\ \(0\)\
\-\ procedure\\:\\ 0\\.01054219870732415\ \(0\)\
\-\ lesion\\:\\ 0\\.010253639033876022\ \(0\)\
\-\ seldom\\:\\ 0\\.010117243409294823\ \(0\)\
\-\ nonsteroidal\\:\\ 0\\.010117243409294823\ \(0\)\
\-\ technetium\\-99m\\:\\ 0\\.009920584509995084\ \(0\)\
\-\ 1\\-\\:\\ 0\\.009920584509995084\ \(0\)\
\-\ brodie\\:\\ 0\\.009747119067202176\ \(0\)\
\-\ desired\\:\\ 0\\.009747119067202176\ \(0\)\
\-\ spasms\\:\\ 0\\.009591948941049267\ \(0\)\
\-\ diphosphonate\\:\\ 0\\.009591948941049267\ \(0\)\
\-\ rigid\\:\\ 0\\.009591948941049267\ \(0\)\
\-\ thirds\\:\\ 0\\.009451580487729202\ \(0\)\
\-\ worsens\\:\\ 0\\.009451580487729202\ \(0\)\
\-\ recurrences\\:\\ 0\\.009451580487729202\ \(0\)\
\-\ view\\:\\ 0\\.009443436314525887\ \(0\)\
\-\ activity\\:\\ 0\\.009443436314525887\ \(0\)\
\-\ appears\\:\\ 0\\.009368862506030187\ \(0\)\
\-\ a\\:\\ 0\\.009345503430187953\ \(0\)\
\-\ island\\:\\ 0\\.009323434129865239\ \(0\)\
\-\ circular\\:\\ 0\\.009323434129865239\ \(0\)\
\-\ concave\\:\\ 0\\.009205550907960177\ \(0\)\
\-\ osteogenic\\:\\ 0\\.00909640809182804\ \(0\)\
\-\ spherical\\:\\ 0\\.008810464035213964\ \(0\)\
\-\ tumor\\:\\ 0\\.008802204572654541\ \(0\)\
\-\ trabeculae\\:\\ 0\\.008726283749735395\ \(0\)\
\-\ 96\\:\\ 0\\.008726283749735395\ \(0\)\
\-\ an\\:\\ 0\\.008701508573525257\ \(0\)\
\-\ enlarged\\:\\ 0\\.008587985479776161\ \(0\)\
\-\ considerable\\:\\ 0\\.008571113623582484\ \(0\)\
\-\ cause\\:\\ 0\\.008516237486161904\ \(0\)\
\-\ appendicular\\:\\ 0\\.008499257711698195\ \(0\)\
\-\ size\\:\\ 0\\.008438515085062655\ \(0\)\
\-\ by\\:\\ 0\\.008382155541943298\ \(0\)\
\-\ sections\\:\\ 0\\.008365278656903312\ \(0\)\
\-\ 4\\-5\\:\\ 0\\.008365278656903312\ \(0\)\
\-\ constitutional\\:\\ 0\\.008302598812398457\ \(0\)\
\-\ osteoblastoma\\:\\ 0\\.008242478054636668\ \(0\)\
\-\ background\\:\\ 0\\.008242478054636668\ \(0\)\
\-\ aspirin\\:\\ 0\\.008242478054636668\ \(0\)\
\-\ superimposed\\:\\ 0\\.008075572774361257\ \(0\)\
\-\ endosteal\\:\\ 0\\.008075572774361257\ \(0\)\
\-\ guidance\\:\\ 0\\.008075572774361257\ \(0\)\
\-\ but\\:\\ 0\\.00805229735360915\ \(0\)\
\-\ anti\\-inflammatory\\:\\ 0\\.007973963243452639\ \(0\)\
\-\ access\\:\\ 0\\.007973963243452639\ \(0\)\
\-\ achieved\\:\\ 0\\.007973963243452639\ \(0\)\
\-\ tolerated\\:\\ 0\\.007925671899088884\ \(0\)\
\-\ image\\:\\ 0\\.007862118310154936\ \(0\)\
\-\ examination\\:\\ 0\\.007824515568408144\ \(0\)\
\-\ approximately\\:\\ 0\\.007787386823433234\ \(0\)\
\-\ initiated\\:\\ 0\\.0077469372054154405\ \(0\)\
\-\ skeleton\\:\\ 0\\.007705448432268613\ \(0\)\
\-\ established\\:\\ 0\\.007705448432268613\ \(0\)\
\-\ alignment\\:\\ 0\\.0076650964820652034\ \(0\)\
\-\ morbidity\\:\\ 0\\.0076650964820652034\ \(0\)\
\-\ usually\\:\\ 0\\.007643382191065564\ \(0\)\
\-\ orthopedics\\:\\ 0\\.007625820713166587\ \(0\)\
\-\ column\\:\\ 0\\.007587565210363552\ \(0\)\
\-\ enough\\:\\ 0\\.007513912160916333\ \(0\)\
\-\ lumbosacral\\:\\ 0\\.007478422394231413\ \(0\)\
\-\ in\\:\\ 0\\.0074473737285464785\ \(0\)\
\-\ connective\\:\\ 0\\.007409909852795636\ \(0\)\
\-\ relieved\\:\\ 0\\.007409909852795636\ \(0\)\
\-\ years\\:\\ 0\\.0073909959853269\ \(0\)\
\-\ increases\\:\\ 0\\.007376812863322796\ \(0\)\
\-\ exertion\\:\\ 0\\.007376812863322796\ \(0\)\
\-\ fairly\\:\\ 0\\.007376812863322796\ \(0\)\
\-\ average\\:\\ 0\\.007344443339436529\ \(0\)\
\-\ effects\\:\\ 0\\.007344443339436529\ \(0\)\
\-\ males\\:\\ 0\\.007251396356194214\ \(0\)\
\-\ when\\:\\ 0\\.007208633984141401\ \(0\)\
\-\ affects\\:\\ 0\\.007163880273026613\ \(0\)\
\-\ toward\\:\\ 0\\.007163880273026613\ \(0\)\
\-\ radiography\\:\\ 0\\.007163880273026613\ \(0\)\
\-\ temperature\\:\\ 0\\.007108298052138768\ \(0\)\
\-\ 95\\:\\ 0\\.007081274283849819\ \(0\)\
\-\ performed\\:\\ 0\\.007017903773865446\ \(0\)\
\-\ females\\:\\ 0\\.0070030565735199985\ \(0\)\
\-\ ratio\\:\\ 0\\.006977880677556375\ \(0\)\
\-\ ovoid\\:\\ 0\\.0069287843295923225\ \(0\)\
\-\ consists\\:\\ 0\\.006904836581622101\ \(0\)\
\-\ recovery\\:\\ 0\\.006858078557594736\ \(0\)\
\-\ gastrointestinal\\:\\ 0\\.006858078557594736\ \(0\)\
\-\ sensitive\\:\\ 0\\.006835244704080796\ \(0\)\
\-\ at\\:\\ 0\\.006820401489435246\ \(0\)\
\-\ data\\:\\ 0\\.006812759472665791\ \(0\)\
\-\ touch\\:\\ 0\\.006790612377872655\ \(0\)\
\-\ therapy\\:\\ 0\\.006729427971253647\ \(0\)\
\-\ lucent\\:\\ 0\\.006726101887948658\ \(0\)\
\-\ successful\\:\\ 0\\.006705211409315438\ \(0\)\
\-\ prolonged\\:\\ 0\\.00668461311480183\ \(0\)\
\-\ intense\\:\\ 0\\.0066642989437674625\ \(0\)\
\-\ percutaneous\\:\\ 0\\.0066642989437674625\ \(0\)\
\-\ called\\:\\ 0\\.006604985395699804\ \(0\)\
\-\ dose\\:\\ 0\\.0065857334346285925\ \(0\)\
\-\ 29\\:\\ 0\\.00656672989289677\ \(0\)\
\-\ useful\\:\\ 0\\.00656672989289677\ \(0\)\
\-\ comparison\\:\\ 0\\.0065479684410890675\ \(0\)\
\-\ choice\\:\\ 0\\.0065111476720089234\ \(0\)\
\-\ minutes\\:\\ 0\\.0065111476720089234\ \(0\)\
\-\ drug\\:\\ 0\\.00645758707676463\ \(0\)\
\-\ for\\:\\ 0\\.006442781873131503\ \(0\)\
\-\ needle\\:\\ 0\\.006405906193390154\ \(0\)\
\-\ containing\\:\\ 0\\.006389074535328853\ \(0\)\
\-\ \\,\\:\\ 0\\.006379029526180557\ \(0\)\
\-\ 100\\:\\ 0\\.006355977545856014\ \(0\)\
\-\ the\\:\\ 0\\.006311823012978497\ \(0\)\
\-\ more\\:\\ 0\\.006295070130521845\ \(0\)\
\-\ series\\:\\ 0\\.006260928177464892\ \(0\)\
\-\ pain\\:\\ 0\\.0061479126216832675\ \(0\)\
\-\ complaining\\:\\ 0\\.006143044955559832\ \(0\)\
\-\ options\\:\\ 0\\.006114991649270149\ \(0\)\
\-\ surgery\\:\\ 0\\.006111926551871208\ \(0\)\
\-\ smaller\\:\\ 0\\.006101162871140783\ \(0\)\
\-\ highly\\:\\ 0\\.0060604389663830366\ \(0\)\
\-\ larger\\:\\ 0\\.0060604389663830366\ \(0\)\
\-\ potential\\:\\ 0\\.0060604389663830366\ \(0\)\
\-\ tissue\\:\\ 0\\.005965894516797036\ \(0\)\
\-\ associated\\:\\ 0\\.005939506809742863\ \(0\)\
\-\ 90\\:\\ 0\\.005932292608519076\ \(0\)\
\-\ margin\\:\\ 0\\.00592007051306297\ \(0\)\
\-\ or\\:\\ 0\\.005899986739108734\ \(0\)\
\-\ major\\:\\ 0\\.005884001264155318\ \(0\)\
\-\ period\\:\\ 0\\.005884001264155318\ \(0\)\
\-\ oblique\\:\\ 0\\.005848794311499127\ \(0\)\
\-\ small\\:\\ 0\\.005798454445894311\ \(0\)\
\-\ can\\:\\ 0\\.005709049639084152\ \(0\)\
\-\ overlying\\:\\ 0\\.005694784290999013\ \(0\)\
\-\ medications\\:\\ 0\\.005613508273963239\ \(0\)\
\-\ sarcoma\\:\\ 0\\.0056036570395732585\ \(0\)\
\-\ apparent\\:\\ 0\\.00556489811716181\ \(0\)\
\-\ under\\:\\ 0\\.005499431603802703\ \(0\)\
\-\ young\\:\\ 0\\.005481249224093867\ \(0\)\
\-\ either\\:\\ 0\\.005481249224093867\ \(0\)\
\-\ facial\\:\\ 0\\.005472241525982768\ \(0\)\
\-\ absent\\:\\ 0\\.005454389743166355\ \(0\)\
\-\ metastases\\:\\ 0\\.005376631001536059\ \(0\)\
\-\ skull\\:\\ 0\\.005359894979959748\ \(0\)\
\-\ osseous\\:\\ 0\\.005343347007548959\ \(0\)\
\-\ etiology\\:\\ 0\\.005326982905302905\ \(0\)\
\-\ before\\:\\ 0\\.005326982905302905\ \(0\)\
\-\ right\\:\\ 0\\.005311527005068728\ \(0\)\
\-\ bones\\:\\ 0\\.005310798631995696\ \(0\)\
\-\ general\\:\\ 0\\.005302772704502964\ \(0\)\
\-\ coronal\\:\\ 0\\.00524009285999811\ \(0\)\
\-\ occurs\\:\\ 0\\.005165317712172744\ \(0\)\
\-\ initially\\:\\ 0\\.005122209638093049\ \(0\)\
\-\ tender\\:\\ 0\\.005108116190352031\ \(0\)\
\-\ treatment\\:\\ 0\\.0050946007646565155\ \(0\)\
\-\ includes\\:\\ 0\\.005073461554990921\ \(0\)\
\-\ conservative\\:\\ 0\\.005026275467001794\ \(0\)\
\-\ sagittal\\:\\ 0\\.005019656336533696\ \(0\)\
\-\ uptake\\:\\ 0\\.0049999755886512695\ \(0\)\
\-\ system\\:\\ 0\\.004955051502799407\ \(0\)\
\-\ pressure\\:\\ 0\\.004942463784716258\ \(0\)\
\-\ unknown\\:\\ 0\\.004911457291052293\ \(0\)\
\-\ rate\\:\\ 0\\.004905333564765601\ \(0\)\
\-\ second\\:\\ 0\\.004833768682237081\ \(0\)\
\-\ used\\:\\ 0\\.0048279589940323445\ \(0\)\
\-\ result\\:\\ 0\\.0048279589940323445\ \(0\)\
\-\ classic\\:\\ 0\\.004822172133737956\ \(0\)\
\-\ within\\:\\ 0\\.00480156526770569\ \(0\)\
\-\ radiographic\\:\\ 0\\.004776678043871478\ \(0\)\
\-\ referred\\:\\ 0\\.004748941742939089\ \(0\)\
\-\ its\\:\\ 0\\.004748941742939089\ \(0\)\
\-\ commonly\\:\\ 0\\.004748941742939089\ \(0\)\
\-\ tumors\\:\\ 0\\.004727122765346835\ \(0\)\
\-\ has\\:\\ 0\\.00472665676139699\ \(0\)\
\-\ occur\\:\\ 0\\.004721718157262944\ \(0\)\
\-\ defect\\:\\ 0\\.004710968079970437\ \(0\)\
\-\ laboratory\\:\\ 0\\.004637837608032497\ \(0\)\
\-\ involvement\\:\\ 0\\.004612575341130805\ \(0\)\
\-\ ap\\:\\ 0\\.004602590529664856\ \(0\)\
\-\ cortical\\:\\ 0\\.004587739102468059\ \(0\)\
\-\ dilated\\:\\ 0\\.00457303594490667\ \(0\)\
\-\ required\\:\\ 0\\.004529787204399505\ \(0\)\
\-\ muscle\\:\\ 0\\.004520346440981362\ \(0\)\
\-\ sclerosis\\:\\ 0\\.004520346440981362\ \(0\)\
\-\ girl\\:\\ 0\\.004424709029440056\ \(0\)\
\-\ side\\:\\ 0\\.0043600095754993675\ \(0\)\
\-\ benign\\:\\ 0\\.004343225871919295\ \(0\)\
\-\ presentation\\:\\ 0\\.004334905205436056\ \(0\)\
\-\ of\\:\\ 0\\.004289536111855244\ \(0\)\
\-\ neoplasm\\:\\ 0\\.004285944883522722\ \(0\)\
\-\ three\\:\\ 0\\.0042424509990381595\ \(0\)\
\-\ possible\\:\\ 0\\.0042385599689014316\ \(0\)\
\-\ initial\\:\\ 0\\.004170224069630793\ \(0\)\
\-\ back\\:\\ 0\\.004151791362809245\ \(0\)\
\-\ vascular\\:\\ 0\\.004126367110344178\ \(0\)\
\-\ positive\\:\\ 0\\.004083778483481762\ \(0\)\
\-\ superior\\:\\ 0\\.004018768331449472\ \(0\)\
\-\ abscess\\:\\ 0\\.003979140271184488\ \(0\)\
\-\ and\\:\\ 0\\.003976634883627801\ \(0\)\
\-\ onset\\:\\ 0\\.003972638035235862\ \(0\)\
\-\ any\\:\\ 0\\.003962938193037251\ \(0\)\
\-\ severe\\:\\ 0\\.003872326656945514\ \(0\)\
\-\ clinical\\:\\ 0\\.003872326656945514\ \(0\)\
\-\ only\\:\\ 0\\.0037841114263401114\ \(0\)\
\-\ treated\\:\\ 0\\.003767085178326744\ \(0\)\
\-\ changes\\:\\ 0\\.0036068453258248315\ \(0\)\
\-\ two\\:\\ 0\\.0036043169920707005\ \(0\)\
\-\ lymphoma\\:\\ 0\\.003596757929881422\ \(0\)\
\-\ focal\\:\\ 0\\.0035942468396736407\ \(0\)\
\-\ abnormal\\:\\ 0\\.003589237467326821\ \(0\)\
\-\ all\\:\\ 0\\.0035595338577780423\ \(0\)\
\-\ secondary\\:\\ 0\\.0035184535589231334\ \(0\)\
\-\ low\\:\\ 0\\.0034995111235145795\ \(0\)\
\-\ shows\\:\\ 0\\.0034600496314121927\ \(0\)\
\-\ been\\:\\ 0\\.003423851089048588\ \(0\)\
\-\ one\\:\\ 0\\.0034105027736533785\ \(0\)\
\-\ mild\\:\\ 0\\.003314069887969274\ \(0\)\
\-\ common\\:\\ 0\\.0032934715934556658\ \(0\)\
\-\ to\\:\\ 0\\.0031448314318334777\ \(0\)\
\-\ symptoms\\:\\ 0\\.003136461674371339\ \(0\)\
\-\ acute\\:\\ 0\\.00310733332710824\ \(0\)\
\-\ physical\\:\\ 0\\.003087636626776492\ \(0\)\
\-\ imaging\\:\\ 0\\.0029485623335134058\ \(0\)\
\-\ with\\:\\ 0\\.0029294123616025415\ \(0\)\
\-\ was\\:\\ 0\\.0029109794468738935\ \(0\)\
\-\ most\\:\\ 0\\.002905500945107623\ \(0\)\
\-\ mri\\:\\ 0\\.0028914224667372897\ \(0\)\
\-\ were\\:\\ 0\\.0028575645606626235\ \(0\)\
\-\ well\\:\\ 0\\.002846952802604788\ \(0\)\
\-\ present\\:\\ 0\\.0028424282090304576\ \(0\)\
\-\ this\\:\\ 0\\.0028310374471697585\ \(0\)\
\-\ it\\:\\ 0\\.0028289372378984047\ \(0\)\
\-\ large\\:\\ 0\\.0027519034342136667\ \(0\)\
\-\ findings\\:\\ 0\\.002678699463608188\ \(0\)\
\-\ after\\:\\ 0\\.002603830931677765\ \(0\)\
\-\ patient\\:\\ 0\\.002523098471035016\ \(0\)\
\-\ also\\:\\ 0\\.002481030329411121\ \(0\)\
\-\ which\\:\\ 0\\.0023492556513145047\ \(0\)\
\-\ that\\:\\ 0\\.0021737565958156457\ \(0\)\
\-\ \\.\\:\\ 0\\.002039001336960979\ \(0\)\
\-\ as\\:\\ 0\\.001903648756839658\ \(0\)\
\-\ not\\:\\ 0\\.001818584199914485\ \(0\)\
\-\ left\\:\\ 0\\.0014081079076184312\ \(0\)\
\-\ year\\:\\ 0\\.0014081079076184312\ \(0\)\
\-\ old\\:\\ 0\\.001288563471078431\ \(0\)\
\-\ no\\:\\ 0\\.0012672226078111958\ \(0\)\
\-\ on\\:\\ 0\\.00106611342027309\ \(0\)\
